U01 CA37429/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	1
2012	2
2013	1
2014	2
2015	2
2016	1
2024	0

1

Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Sutcliffe S, Till C, Gaydos CA, Jenkins FJ, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Zenilman JM, Nelson WG, De Marzo AM, Platz EA. Sutcliffe S, et al. Cancer Causes Control. 2012 Sep;23(9):1511-8. doi: 10.1007/s10552-012-0028-5. Epub 2012 Jul 19. Cancer Causes Control. 2012. PMID: 22810146 Free PMC article. Clinical Trial.

2

Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

Brasky TM, Till C, White E, Neuhouser ML, Song X, Goodman P, Thompson IM, King IB, Albanes D, Kristal AR. Brasky TM, et al. Am J Epidemiol. 2011 Jun 15;173(12):1429-39. doi: 10.1093/aje/kwr027. Epub 2011 Apr 24. Am J Epidemiol. 2011. PMID: 21518693 Free PMC article. Clinical Trial.

3

Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.

Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia MS, Hoque A, Hsing AW, Thompson IM, Pollak M. Neuhouser ML, et al. Cancer Prev Res (Phila). 2013 Feb;6(2):91-9. doi: 10.1158/1940-6207.CAPR-12-0250. Epub 2013 Jan 11. Cancer Prev Res (Phila). 2013. PMID: 23315596 Free PMC article. Clinical Trial.

4

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.

Schenk JM, Till CA, Tangen CM, Goodman PJ, Song X, Torkko KC, Kristal AR, Peters U, Neuhouser ML. Schenk JM, et al. Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1484-93. doi: 10.1158/1055-9965.EPI-13-1340. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25085836 Free PMC article. Clinical Trial.

5

Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Sutcliffe S, Till C, Jenkins FJ, Gaydos CA, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Nelson WG, De Marzo AM, Platz EA. Sutcliffe S, et al. Cancer Causes Control. 2015 Jan;26(1):35-44. doi: 10.1007/s10552-014-0480-5. Epub 2014 Oct 31. Cancer Causes Control. 2015. PMID: 25359302 Free PMC article.

6

Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.

Patel DP, Schenk JM, Darke A, Myers JB, Brant WO, Hotaling JM. Patel DP, et al. BJU Int. 2016 Mar;117(3):500-6. doi: 10.1111/bju.13264. Epub 2015 Sep 20. BJU Int. 2016. PMID: 26305866 Free PMC article. Clinical Trial.

7

Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons JK, Thompson IM, Kristal AR. Schenk JM, et al. Am J Epidemiol. 2012 Jul 15;176(2):156-63. doi: 10.1093/aje/kwr524. Epub 2012 Jun 28. Am J Epidemiol. 2012. PMID: 22759721 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year